Connection

Perry Molinoff to Cell Line

This is a "connection" page, showing publications Perry Molinoff has written about Cell Line.
Connection Strength

0.437
  1. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
    View in: PubMed
    Score: 0.040
  2. Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6.
    View in: PubMed
    Score: 0.028
  3. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol. 1995 Nov; 48(5):956-64.
    View in: PubMed
    Score: 0.024
  4. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45.
    View in: PubMed
    Score: 0.023
  5. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J Biol Chem. 1994 Dec 16; 269(50):31850-7.
    View in: PubMed
    Score: 0.022
  6. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J Pharmacol Exp Ther. 1994 Dec; 271(3):1574-82.
    View in: PubMed
    Score: 0.022
  7. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42.
    View in: PubMed
    Score: 0.021
  8. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
    View in: PubMed
    Score: 0.020
  9. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol. 1990 May; 37(5):622-30.
    View in: PubMed
    Score: 0.016
  10. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system. J Pharmacol Exp Ther. 1988 Sep; 246(3):1040-7.
    View in: PubMed
    Score: 0.014
  11. Interactions of beta-adrenergic receptors with a membrane protein other than the stimulatory guanine nucleotide-binding protein. Biochem Pharmacol. 1987 Jul 15; 36(14):2263-9.
    View in: PubMed
    Score: 0.013
  12. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60.
    View in: PubMed
    Score: 0.013
  13. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Oct; 239(1):136-43.
    View in: PubMed
    Score: 0.013
  14. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.013
  15. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11.
    View in: PubMed
    Score: 0.012
  16. Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activity. Biochem Pharmacol. 1986 Jul 15; 35(14):2331-5.
    View in: PubMed
    Score: 0.012
  17. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
    View in: PubMed
    Score: 0.012
  18. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):154-64.
    View in: PubMed
    Score: 0.012
  19. Properties of beta-adrenergic receptors of cultured mammalian cells. Interaction of receptors with a guanine nucleotide-binding protein in membranes prepared from L6 myoblasts and from wild-type and cyc- S49 lymphoma cells. J Biol Chem. 1985 Nov 25; 260(27):14580-8.
    View in: PubMed
    Score: 0.012
  20. Interactions of agonists with beta-adrenergic receptors on S49 lymphoma cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:13-27.
    View in: PubMed
    Score: 0.011
  21. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists. Biochem Pharmacol. 1984 Nov 15; 33(22):3579-84.
    View in: PubMed
    Score: 0.011
  22. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J Pharmacol Exp Ther. 1984 Sep; 230(3):614-8.
    View in: PubMed
    Score: 0.011
  23. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol. 1984 Mar; 25(2):209-18.
    View in: PubMed
    Score: 0.011
  24. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.010
  25. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol Pharmacol. 1983 Nov; 24(3):398-408.
    View in: PubMed
    Score: 0.010
  26. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
    View in: PubMed
    Score: 0.009
  27. Increased membrane acyl chain ordering activates adenylate cyclase. J Biol Chem. 1979 Sep 25; 254(18):9135-41.
    View in: PubMed
    Score: 0.008
  28. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9.
    View in: PubMed
    Score: 0.006
  29. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol. 1989 Aug; 257(2 Pt 1):E277-83.
    View in: PubMed
    Score: 0.004
  30. Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem. 1978 Mar 10; 253(5):1472-80.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.